Nabriva Therapeutics plc (NBRVF) Financials
Stock symbol NBRVF is outdated, potentially delisted? Maybe it is available on other exchange?
NBRVF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2023 | 10.6 million | 26.9 million |
| March 31, 2023 | 24.3 million | 28.7 million |
| Dec. 31, 2022 | 31.8 million | 28.5 million |
| Sept. 30, 2022 | 48.2 million | 22.6 million |
NBRVF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2023 | 511000 | 98000 |
| March 31, 2023 | -5.6 million | 999000 |
| Dec. 31, 2022 | -1.6 million | 135000 |
| Sept. 30, 2022 | -6.3 million | 498000 |
NBRVF Net Income
No data available :(
NBRVF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2023 | 2.2 million | 344000 | - |
| March 31, 2023 | 1.8 million | 345000 | - |
| Dec. 31, 2022 | 12.4 million | 388000 | - |
| Sept. 30, 2022 | 14.6 million | 399000 | - |
NBRVF Shares Outstanding
NBRVF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2023 | - | 1.1 million | 4.1 million | - |
| March 31, 2023 | 3000 | 2.6 million | 9.0 million | - |
| Dec. 31, 2022 | 9000 | 2.6 million | 9.6 million | - |
| Sept. 30, 2022 | 103000 | 4.0 million | 11.9 million | - |
NBRVF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2023 | 2.6 million | 9.1 million |
| March 31, 2023 | 7.6 million | 4.4 million |
| Dec. 31, 2022 | 10.4 million | 16.3 million |
| Sept. 30, 2022 | 8.8 million | 4.4 million |
NBRVF
Price: $0
52 week price:
Earnings Per Share: -36.74 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 646